½Å·ÏÀÌ ¹«¸£ÀÍ°í Á¡Â÷ ´õÀ§¸¦ ´À³¢°Ô ÇÏ´Â °èÀýÀÔ´Ï´Ù. ´ëÇѳ»ºÐºñÇÐȸ¿¡¼­´Â ³»ºÐºñÇÐÀ» Àü°øÇÏ´Â ÀüÀÓÀǸ¸À» ´ë»óÀ¸·Î ÇÏ¿© ÀÓ»ó ³»ºÐºñÇп¡ ´ëÇØ ÇØ´ç ºÐ¾ßÀÇ ±ÇÀ§ÀÚ¸¦ ¸ð½Ã°í ½Éµµ ÀÖ´Â ¸®ºäÀÇ ½Ã°£À» °¡Áö°íÀÚ Á¦8ȸ ÀüÀÓÀÇ ¿¬¼ö°­Á¸¦ ÁغñÇÏ¿´À¸´Ï ¸¹Àº Âü¼®À» ºÎŹµå¸³´Ï´Ù.
°¨»çÇÕ´Ï´Ù.

2010³â 5¿ù
´ëÇѳ»ºÐºñÇÐȸ ȸÀå ±è¿ë±â/ ÀÌ»çÀå Àӽ±æ
7¿ù 2ÀÏ(±Ý)
  µî·ÏÈ®ÀÎ ³»ºÐºñÇÐȸ
  Àλç ȸÀå ±è¿ë±â
  ½Å°æ³»ºÐºñ ¹× ³úÇϼöü ÁÂÀå - ±è¼º¿î
9:00~9:25 ³»ºÐºñ ¿µ»ó: CT & MRI of Hypothalamus and Pituitary Gland and it¡¯s Disorders ¿¬¼¼ÀÇ´ë ¿µ»óÀÇÇаú À̽±¸
9:25~9:50 Pre-Op Evaluation and Post-Op Management of Sellar Masses ÀÎÁ¦ÀÇ´ë ¹ÚÁ¤Çö
9:50~10:15 Medical Treatment of Prolactinoma and Acromegaly ÇѾçÀÇ´ë ±èµ¿¼±
10:15~10:40 Disorders of Posterior Pituitary Gland °üµ¿ÀÇ´ë ±èÇüÁø
10:40~11:00 ÁúÀÇÀÀ´ä ¹× ÈÞ½Ä
  °©»ó¼± ÁÂÀå - ±Ã¼º¼ö
11:00~11:25 Antithyroidal Drugs, Radioactive Iodine and Thyroidectomy ¼­¿ïÀÇ´ë ¹Ú¿µÁÖ
11:25~11:50 Thyroid Cytology Review ¿ï»êÀÇ´ë º´¸®°ú °ø°æ¿±
11:50~12:15 Pregnancy and Thyroid Diseases °üµ¿ÀÇ´ë ÀÓâÈÆ
12:15~12:40 Hashimoto¡¯s thyroiditis ¼º±Õ°üÀÇ´ë Á¤ÀçÈÆ
12:40~1:50 Áß½Ä
  ´ç´¢º´, ÁöÁú´ë»ç ¹× »ý½Ä  ÁÂÀå - ¹Ú¼º¿ì
1:50~2:15 Genetic Factors in the Development of Type 2 Diabetes ¼­¿ïÀÇ´ë ¹Ú°æ¼ö
2:15~2:40 Autoimmunity in Diabetes ÇѾçÀÇ´ë ¹Ú¿ë¼ö
2:40~3:05 Primary Disorders of Hyperlipidemias ¿ø±¤ÀÇ´ë ¹Úº´Çö
3:05~3:30 MEN (Multiple Endocrine Neoplasia) ÇѸ²ÀÇ´ë ±èö½Ä
3:30~3:50 ÁúÀÇ ÀÀ´ä ¹× ÈÞ½Ä
  °ñ´ë»ç ¹× Ư°­  ÁÂÀå - Àӽ±æ
3:50~4:15 Disorders of Phosphorus Homeostasis °¡Å縯ÀÇ´ë ¹é±âÇö
4:15~4:40 Assessment of Bone Strength ¾ÆÁÖÀÇ´ë Á¤À±¼®
4:40~5:05 Estrogen and Bone Health ¼øõÇâÀÇ´ë º¯µ¿¿ø
5:05~5:30 Bisphosphonate Treatment Àü³²ÀÇ´ë Á¤µ¿Áø
  Ư°­ ¿¬ÀÚ¼Ò°³: Àӽ±æ
5:30~6:10 ´ëÇÑ ³»ºÐºñÇÐȸÀÇ ¹ßÀÚÃë (⸳°ú ¹ßÀü) CHAÀÇ°úÇдëÇб³ ÃÖ¿µ±æ
6:10~6:30 ÈÞ½Ä ¹× Á¤¸®
6:30~7:10 ¼®½Ä
7:10~9:00 Ä£±³ÀÇ ½Ã°£ Ãѹ«ÀÌ»ç
7¿ù 3ÀÏ(Åä)
  Molecular Endocrinology Review ÁÂÀå - ÀÌÀºÁ÷ 
8:00~8:30 Thyroid Hormone Action Ãæ³²ÀÇ´ë ¼Û¹ÎÈ£
8:30~9:00 Adipocyte Biology: Adipogenesis and Adipocytokines ¿¬¼¼ÀÇ´ë Â÷ºÀ¼ö
9:00~9:30 Beta Cell Biology: Development and Maintenance of Beta Cell Mass °¡Å縯ÀÇ´ë À±°ÇÈ£
9:30~10:00 Bone Biology: Osteoblast, Osteoclast, and Osteocyte Interaction °æÈñÀÇ´ë Á¤È£¿¬
10:00~10:20 ÁúÀÇÀÀ´ä ¹× ÈÞ½Ä  
  Vascular Endocrinology ÁÂÀå - ±è¼º¿¬
10:20~10:50 Renin-Angiotensin system & Essential and Secondary Hypertension ¼º±Õ°üÀÇ´ë ¹Ú¼¼Àº
10:50~11:20 Endothelial Dysfunction and Diabetic Complications °æºÏÀÇ´ë ±èÁ¤±¹
11:20~11:50 Molecular biology of Atherosclerosis °æÈñÀÇ´ë Á¤Àΰæ
11:50~1:00 Áß½Ä
  ºÎ½Å ¹× ±âŸ Áúȯ ÁÂÀå - ±è¿ë±â
1:00~1:25 Differential Diagnosis of Cushing Syndrome °æÈñÀÇ´ë ¿À½ÂÁØ
1:25~1:50 Diagnostic and Therapeutic Approaches to Pheochromocytoma and Paraganglioma °í·ÁÀÇ´ë ±è½Å°ï
1:50~2:15 Primary Mineralcorticoid-Excess States ¼­¿ïÀÇ´ë ±è»ó¿Ï
2:15~2:40 Gynecomastia and Hirsutism ÀÌÈ­ÀÇ´ë ¼º¿¬¾Æ
2:40~3:00 Á¾ÇÕÁúÀÇ
3:00~3:30 Æóȸ»ç ¹× ¼ö·áÁõ ÁõÁ¤ ÀÌ»çÀå Àӽ±æ
¤ý ´ë      »ó : ³»ºÐºñ³»°ú ÀüÀÓÀÇ ¹× ÀüÀÓÀÇ ¼ö·áÀÚ(ºÐ°úÀü¹®ÀÇ ½ÃÇèÀ» Áغñ ÁßÀÎ ÀÚ)
Àü°øÀÇ ÇØ´ç ¾øÀ½.
¤ý ÀÏ      Á¤ : 2010³â 7¿ù 2ÀÏ ~ 3ÀÏ(±Ý, Åä)
¤ý Àå      ¼Ò : ÀÎõ°øÇ× ÇϾæÆ® ¸®Á¨½ÃÈ£ÅÚ
¤ý Æò      Á¡ : 2ÀÏ-6Á¡, 3ÀÏ-5Á¡(´ëÇÑÀÇ»çÇùȸ, ´ëÇѳ»°úÇÐȸ)
¤ý µî  ·Ï ºñ : ÇÐȸȸ¿ø : Æò»ýȸ¿ø - 20¸¸¿ø, Á¤È¸¿ø - 30¸¸¿ø
ºñȸ¿ø : 40¸¸¿ø
¤ý ¼÷  ¹Ú ºñ : 1¹Ú(7¿ù 2ÀÏ) - 5¸¸¿ø, 2ÀÎ 1½Ç ±âÁØ
¤ý µî·Ï±â°£ : 5¿ù 27ÀÏ(¸ñ) ~ 6¿ù 16ÀÏ(¼ö)
¡Ø Áغñ°ü°è·Î »çÀüµî·Ï¸¸ ¹Þ½À´Ï´Ù.
¤ý µî·Ï¹æ¹ý : ¹«ÅëÀå ÀÔ±Ý/½Å¿ëÄ«µå ÀüÀÚ°áÁ¦ °¡´É
½Åû¼­ ÀÛ¼º ÈÄ ¹«ÅëÀå ¹× ½Å¿ëÄ«µå·Î °áÁ¦ÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
¤ý ¼Û±Ý±¸Á : ¼Û±Ý±¸Á : 803-25-0006-851(±¹¹ÎÀºÇà, ¿¹±ÝÁÖ-´ëÇѳ»ºÐºñÇÐȸ)
* ¼÷¹Ú½ÅûÀº µî·Ï°ú ÇÔ²² ½ÅûÇϼž߸¸ 󸮰¡ °¡´ÉÇϸç, µî·Ï±â°£ ÀÌÈÄ¿¡´Â Ãë¼Ò ¹× Ãß°¡°¡
   ºÒ°¡´ÉÇÏ¿À´Ï ½ÅÁßÇÏ°Ô »ý°¢Çϼż­ µî·ÏÇϽñ⠹ٶø´Ï´Ù.
¤ý¿À½Ã´Â ±æ :
ÇϾæÆ® ¸®Á¨½Ã ÀÎõÀº ÀÎõ±¹Á¦°øÇ×ÀÇ ¿©°´Å͹̳ο¡¼­ ³²ÂÊÀ¸·Î 1.5KM¿¡ À§Ä¡ÇÑ ±¹Á¦¾÷¹«¼¾ÅÍ¿¡ À§Ä¡ÇÏ°í ÀÖ½À´Ï´Ù.

¤ý½Â¿ëÂ÷ ÀÌ¿ë½Ã :
½Å°øÇ× Åç°ÔÀÌÆ®¸¦ Áö³ª ¿µÁ¾´ë±³¸¦ °Ç³Ê ¾à 10~15ºÐ Á¤µµ Á÷Áø ÈÄ °øÇ׽ŵµ½Ã ÁøÀԷθ¦ Áö³ª½Ã¸é ¿ÞÆí¿¡ GS ÁÖÀ¯¼Ò°¡ º¸ÀÔ´Ï´Ù. GS ÁÖÀ¯¼Ò¸¦ Áö³ªÀÚ¸¶ÀÚ ¿À¸¥ÂÊ¿¡ º¸ÀÌ´Â ±¹Á¦¾÷¹«´ÜÁö ÁøÀԷηΠ³ª¿À½Ã¸é 1~2ºÐ ÈÄ µµ·Î ¿ÞÂÊ ³¡¿¡¼­ ÇϾæÆ® ¸®Á¨½Ã ÀÎõÀ» ¸¸³ªº¸½Ç ¼ö ÀÖ½À´Ï´Ù.

¤ý°øÇ× ¼øȯ¼ÅƲ ÀÌ¿ë½Ã :
ÀÎõ±¹Á¦°øÇ× µµÂø ÈÄ(ÀÎõ±¹Á¦°øÇ× Çà ¹ö½º³ë¼± ¾È³»), ¿©°´ Å͹̳Π3Ãþ(Ãâ±¹Ãþ) 3¹ø, 12¹ø °ÔÀÌÆ®¿¡¼­ °øÇ× ¼øȯ ¼ÅƲ(È­¹°Å͹̳ΠÇà)ÀÌ 8~12ºÐ °£°ÝÀ¸·Î ¹«·á ¿îÇàµË´Ï´Ù.
* °øÇ׿¡¼­ È£ÅÚ±îÁö ¼Ò¿ä½Ã°£ ¾à 3ºÐ

¤ýÈ£ÅÚ ¼ÅƲ ÀÌ¿ë½Ã :
ÀÎõ±¹Á¦°øÇ× µµÂø ÈÄ(ÀÎõ±¹Á¦°øÇ× Çà ¹ö½º³ë¼± ¾È³»), ¿©°´ Å͹̳Π1Ãþ(µµÂøÃþ) 1¹ø °ÔÀÌÆ®¿¡¼­ ÇϾæÆ® ¸®Á¨½Ã ÀÎõ ¼ÅƲÀ» ÀÌ¿ëÇϽʽÿÀ.
¸Å 15ºÐ °£°Ý(ùÂ÷ 05:07 ¸·Â÷ 23:00)À¸·Î °øÇ×°ú È£ÅÚ »çÀ̸¦ ¹«·á·Î ¿îÇàÇÕ´Ï´Ù.
* °øÇ׿¡¼­ È£ÅÚ±îÁö ¼Ò¿ä½Ã°£ ¾à 3ºÐ

¤ýKAL ¸®¹«Áø ÀÌ¿ë½Ã :
±èÆ÷°øÇ× (ùÂ÷: 04:00 ¸·Â÷: 21:50) ¡ê ÇϾæÆ® ¸®Á¨½Ã ÀÎõ(ùÂ÷: 05:10 ¸·Â÷:22:15)
* °æÀ¯ ³ë¼± - ±èÆ÷°øÇ× <-> ÀÎõ±¹Á¦°øÇ× <-> ÇϾæÆ® ¸®Á¨½Ã ÀÎõ
* ¸®¹«ÁøÀº 20~30ºÐ °£°ÝÀ¸·Î ¿îÇàµÇ¸ç, ÇϾæÆ® ¸®Á¨½Ã ÀÎõ È£ÅÚ Á¤¹® ¾Õ¿¡¼­ Á¤Â÷ÇÕ´Ï´Ù.
*ÀÚ¼¼ÇÑ ½ÂÂ÷ ½ºÄÉÁì º¸±â http://www.kallimousine.com